We are an ophthalmic medicines company recently established in Malta as a part of our expansion plan into the EU and beyond. Our parent companies, Blumont Pharma and Blumont Healthcare, were first set up in the United Kingdom in 2005.
We specialise in the development and licensing out of products to improve ocular health as well as to treat various ocular diseases. We currently supply ophthalmic medicines to wholesalers in the Norway, Sweden, Belgium, Luxemburg and are looking for partners to collaborate in new markets in Europe and other continents for our products. We manufacture our products at specially chosen subcontractors and under GMP conditions.
And working with distributors, we also actively license out our products to interested partners on mutually acceptable terms. All our products under development will have Marketing Authorisation dossiers at current EU (CTD) standards.
We are an ophthalmic medicines company established in 2005 and located in Grantham, England.
We are an ophthalmic medicines company established in 2005 and located in Grantham, England. It is managed by Dr Sunder Raj and Ms Jane Whitton.
Dr Sunderraj is a qualified ophthalmologist and pharmaceutical physician with over 16 years experience within the pharmaceutical industry. He has worked at country, regional, and global levels in blue chip companies such as Novartis, Boots and CIBA in a variety of medical, clinical research, marketing, and general management positions.
Jane Whitton has a strong background in administration, project management and financial management with great emphasis on customer care, since joining the ophthalmic pharmaceutical industry in 1991. Jane has worked in a variety of roles of increasing seniority in regulatory affairs, medical affairs, supply chain management and general management.